Cecilia Karlsson

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 19

Top Topics

Bariatric Surgery

Roux En Y Gastric Bypass

Top Venues

Clinical pharmacology and therapeutics

Clinical and translational science

International journal of obesity (2005)

This page only lists publications with an associated author ORCID identifier.

Publications

Kine Eide Kvitne, Jøran Hjelmesæth, Markus Herberg Hovd, Rune Sandbu, Line Kristin Johnson, Shalini Andersson, Cecilia Karlsson, Hege Christensen, Rasmus Jansson-Löfmark, Anders Asberg, Ida Robertsen
Oral Drug Dosing After Gastric Bypass and Diet-Induced Weight Loss: Simpler Than We Think? Lessons Learned From the COCKTAIL Study. Clinical pharmacology and therapeutics (2024)
Kine Eide Kvitne, Jøran Hjelmesæth, Markus Herberg Hovd, Rune Sandbu, Line Kristin Johnson, Shalini Andersson, Cecilia Karlsson, Hege Christensen, Rasmus Jansson-Löfmark, Anders Asberg, Ida Robertsen
Oral Drug Dosing After Gastric Bypass and Diet-Induced Weight Loss: Simpler Than We Think? Lessons Learned From the COCKTAIL Study. Clinical pharmacology and therapeutics 116 (3) (2024)
Lena M S Carlsson, Björn Carlsson, Peter Jacobson, Cecilia Karlsson, Johanna C Andersson Assarsson, Felipe M Kristensson, Sofie Ahlin, Per-Arne Svensson, Magdalena Taube, Ingmar Näslund, Kristjan Karason, Markku Peltonen, Kajsa Sjöholm
Life expectancy after bariatric surgery or usual care in patients with or without baseline type 2 diabetes in Swedish Obese Subjects. International journal of obesity (2005) (2023)
Heather E Danysh, Catherine B Johannes, Daniel C Beachler, J Bradley Layton, Ryan Ziemiecki, Alejandro Arana, Jade Dinh, Ling Li, Brian Calingaert, Manel Pladevall, Phillip R Hunt, Hungta Chen, Cecilia Karlsson, Kristina Johnsson, Alicia W Gilsenan
Post-Authorization Safety Studies of Acute Liver Injury and Severe Complications of Urinary Tract Infection in Patients with Type 2 Diabetes Exposed to Dapagliflozin in a Real-World Setting. Drug safety (2022)
Catherine B Johannes, Daniel C Beachler, J Bradley Layton, Heather E Danysh, Ryan Ziemiecki, Alejandro Arana, Jade Dinh, Ling Li, Brian Calingaert, Manel Pladevall, Phillip R Hunt, Hungta Chen, Cecilia Karlsson, Kristina Johnsson, Alicia W Gilsenan
Post-Authorization Safety Study of Hospitalization for Acute Kidney Injury in Patients with Type 2 Diabetes Exposed to Dapagliflozin in a Real-World Setting. Drug safety 46 (2) (2022)
Catherine B Johannes, Daniel C Beachler, J Bradley Layton, Heather E Danysh, Ryan Ziemiecki, Alejandro Arana, Jade Dinh, Ling Li, Brian Calingaert, Manel Pladevall, Phillip R Hunt, Hungta Chen, Cecilia Karlsson, Kristina Johnsson, Alicia W Gilsenan
Post-Authorization Safety Study of Hospitalization for Acute Kidney Injury in Patients with Type 2 Diabetes Exposed to Dapagliflozin in a Real-World Setting. Drug safety 46 (2) (2022)
Heather E Danysh, Catherine B Johannes, Daniel C Beachler, J Bradley Layton, Ryan Ziemiecki, Alejandro Arana, Jade Dinh, Ling Li, Brian Calingaert, Manel Pladevall, Phillip R Hunt, Hungta Chen, Cecilia Karlsson, Kristina Johnsson, Alicia W Gilsenan
Post-Authorization Safety Studies of Acute Liver Injury and Severe Complications of Urinary Tract Infection in Patients with Type 2 Diabetes Exposed to Dapagliflozin in a Real-World Setting. Drug safety 46 (2) (2022)
Catherine B Johannes, Daniel C Beachler, J Bradley Layton, Heather E Danysh, Ryan Ziemiecki, Alejandro Arana, Jade Dinh, Ling Li, Brian Calingaert, Manel Pladevall, Phillip R Hunt, Hungta Chen, Cecilia Karlsson, Kristina Johnsson, Alicia W Gilsenan
Post-Authorization Safety Study of Hospitalization for Acute Kidney Injury in Patients with Type 2 Diabetes Exposed to Dapagliflozin in a Real-World Setting. Drug safety 46 (2) (2022)
Catherine B Johannes, Daniel C Beachler, J Bradley Layton, Heather E Danysh, Ryan Ziemiecki, Alejandro Arana, Jade Dinh, Ling Li, Brian Calingaert, Manel Pladevall, Phillip R Hunt, Hungta Chen, Cecilia Karlsson, Kristina Johnsson, Alicia W Gilsenan
Post-Authorization Safety Study of Hospitalization for Acute Kidney Injury in Patients with Type 2 Diabetes Exposed to Dapagliflozin in a Real-World Setting. Drug safety 46 (2) (2022)
Heather E Danysh, Catherine B Johannes, Daniel C Beachler, J Bradley Layton, Ryan Ziemiecki, Alejandro Arana, Jade Dinh, Ling Li, Brian Calingaert, Manel Pladevall, Phillip R Hunt, Hungta Chen, Cecilia Karlsson, Kristina Johnsson, Alicia W Gilsenan
Post-Authorization Safety Studies of Acute Liver Injury and Severe Complications of Urinary Tract Infection in Patients with Type 2 Diabetes Exposed to Dapagliflozin in a Real-World Setting. Drug safety 46 (2) (2022)
Heather E Danysh, Catherine B Johannes, Daniel C Beachler, J Bradley Layton, Ryan Ziemiecki, Alejandro Arana, Jade Dinh, Ling Li, Brian Calingaert, Manel Pladevall, Phillip R Hunt, Hungta Chen, Cecilia Karlsson, Kristina Johnsson, Alicia W Gilsenan
Post-Authorization Safety Studies of Acute Liver Injury and Severe Complications of Urinary Tract Infection in Patients with Type 2 Diabetes Exposed to Dapagliflozin in a Real-World Setting. Drug safety 46 (2) (2022)
Catherine B Johannes, Daniel C Beachler, J Bradley Layton, Heather E Danysh, Ryan Ziemiecki, Alejandro Arana, Jade Dinh, Ling Li, Brian Calingaert, Manel Pladevall, Phillip R Hunt, Hungta Chen, Cecilia Karlsson, Kristina Johnsson, Alicia W Gilsenan
Post-Authorization Safety Study of Hospitalization for Acute Kidney Injury in Patients with Type 2 Diabetes Exposed to Dapagliflozin in a Real-World Setting. Drug safety 46 (2) (2022)
Heather E Danysh, Catherine B Johannes, Daniel C Beachler, J Bradley Layton, Ryan Ziemiecki, Alejandro Arana, Jade Dinh, Ling Li, Brian Calingaert, Manel Pladevall, Phillip R Hunt, Hungta Chen, Cecilia Karlsson, Kristina Johnsson, Alicia W Gilsenan
Post-Authorization Safety Studies of Acute Liver Injury and Severe Complications of Urinary Tract Infection in Patients with Type 2 Diabetes Exposed to Dapagliflozin in a Real-World Setting. Drug safety 46 (2) (2022)
Kine Eide Kvitne, Anders Asberg, Line K Johnson, Christine Wegler, Jens K Hertel, Per Artursson, Cecilia Karlsson, Shalini Andersson, Rune Sandbu, Eva Skovlund, Hege Christensen, Rasmus Jansson-Löfmark, Jøran Hjelmesaeth, Ida Robertsen
Impact of type 2 diabetes on in vivo activities and protein expressions of cytochrome P450 in patients with obesity. Clinical and translational science 15 (11) (2022)
Catherine B Johannes, Daniel C Beachler, J Bradley Layton, Heather E Danysh, Ryan Ziemiecki, Alejandro Arana, Jade Dinh, Ling Li, Brian Calingaert, Manel Pladevall, Phillip R Hunt, Hungta Chen, Cecilia Karlsson, Kristina Johnsson, Alicia W Gilsenan
Post-Authorization Safety Study of Hospitalization for Acute Kidney Injury in Patients with Type 2 Diabetes Exposed to Dapagliflozin in a Real-World Setting. Drug safety 46 (2) (2022)
Heather E Danysh, Catherine B Johannes, Daniel C Beachler, J Bradley Layton, Ryan Ziemiecki, Alejandro Arana, Jade Dinh, Ling Li, Brian Calingaert, Manel Pladevall, Phillip R Hunt, Hungta Chen, Cecilia Karlsson, Kristina Johnsson, Alicia W Gilsenan
Post-Authorization Safety Studies of Acute Liver Injury and Severe Complications of Urinary Tract Infection in Patients with Type 2 Diabetes Exposed to Dapagliflozin in a Real-World Setting. Drug safety 46 (2) (2022)
Heather E Danysh, Catherine B Johannes, Daniel C Beachler, J Bradley Layton, Ryan Ziemiecki, Alejandro Arana, Jade Dinh, Ling Li, Brian Calingaert, Manel Pladevall, Phillip R Hunt, Hungta Chen, Cecilia Karlsson, Kristina Johnsson, Alicia W Gilsenan
Post-Authorization Safety Studies of Acute Liver Injury and Severe Complications of Urinary Tract Infection in Patients with Type 2 Diabetes Exposed to Dapagliflozin in a Real-World Setting. Drug safety 46 (2) (2022)
Catherine B Johannes, Daniel C Beachler, J Bradley Layton, Heather E Danysh, Ryan Ziemiecki, Alejandro Arana, Jade Dinh, Ling Li, Brian Calingaert, Manel Pladevall, Phillip R Hunt, Hungta Chen, Cecilia Karlsson, Kristina Johnsson, Alicia W Gilsenan
Post-Authorization Safety Study of Hospitalization for Acute Kidney Injury in Patients with Type 2 Diabetes Exposed to Dapagliflozin in a Real-World Setting. Drug safety (2022)
Cecilia Karlsson, Peter J Greasley, David Gustafsson, Karin Wåhlander
Development of Human Target Validation Classification that Predicts Future Clinical Efficacy. The Journal of pharmacology and experimental therapeutics 368 (2) (2018)